3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
14
Pain
13
Pain, Postoperative
12
Cancer Pain
10
Agnosia
7
Chronic Pain
6
Colorectal Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Mucositis
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Supratentorial Neoplasms
2
Pancreatic Neoplasms
2
Pain, Intractable
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Inflammation
2
Ileus
2
Hematologic Neoplasms
2
Wounds and Injuries
1
Waldenstrom Macroglobulinemia
1
Vesico-Ureteral Reflux
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Temozolomide
3
Irinotecan
3
Bevacizumab
3
Sorafenib
2
Radiosurgery
2
pembrolizumab
1
ibrutinib
1
Vorinostat
1
Valproic Acid
1
Transcranial Magnetic Stimulation
1
Therapeutics
1
Thalidomide
1
Surveys and Questionnaires
1
Standard of Care
1
Sildenafil Citrate
1
Radiotherapy
1
Palliative Care
1
Nivolumab
1
Morphine
1
Methadone
1
Lenalidomide
1
Laparoscopy
1
Equipment and Supplies
1
Eating
1
Cytidine Triphosphate
1
Bendamustine Hydrochloride
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurologic Manifestations
×
Morphine
×
Clear all
NCT04475029
2023-09-13
METAMORF
University of Aarhus
Phase NA
Completed
114 enrolled